Publish in this journal
Journal Information
Vol. 22. Num. 6.January 2011Pages 488-607
Share
Share
Download PDF
More article options
Vol. 22. Num. 6.January 2011Pages 488-607
DOI: 10.1016/S1130-1473(11)70108-7
Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital
Análisis clínico económico de las infecciones nosocomiales en los pacientes diagnosticados de tumoración cerebral en un hospital terciario
Visits
2012
J. Undabeitia??
Corresponding author
Department of Neurosurgery. Arnau Hospital. Villanova. Lleida
B.G. Liu**, G. Catalán*,***, G. Bilbao*,***, I. Pomposo*,***, J.M. Garibi*,***
* Department of Neurosurgery. Cruces Hospital. University of the Basque Country
** Department of Neurosurgery. Johns Hopkins Medical Institutions. University of the Basque Country
*** Department of Surgery. University of the Basque Country
Visits
2012
Article information
Summary
Objectives

To analyze the relationship between hospital acquired infections and clinical outcomes, duration of stay, and cost per infectious episode in patients diagnosed with brain tumors in our service.

Materials and methods

We conducted a retrospective study on patients diagnosed with brain tumors and admitted to the department of neurosurgery in the Cruces Hospital of the University of the Basque Country between January 1st, 2007 and December 31st, 2007. We collected demographics, responsible pathogens, infection location, length of hospitalization, and costs of various medical and surgical procedures performed.

Results

We reviewed 139 patients that accumulated 210 hospital visits. We found 34 episodes of hospital acquired infections (16.25% of patients). The most frequent infections were that of the lower respiratory tract, urinary tract, and surgical site. We found that patients with HAIs had a significantly lower final KPS score (sig <0.01), greater mean cost of stay (17097€, sig.<0.01), and longer length of stay (15.45 days, sig<0.01). We did not find a significant difference in mortality.

Conclusions

We found significant association between the presence of HAIs and worse clinical outcomes, higher costs, and longer length of stay. The pathogens responsible and infection locations were similar to existing series in the literature. Although variability in study designs in the literature makes interpretation and comparison of results difficult, measures to prevent these complications can improve quality of care and reduce costs.

Key words:
Brain neoplasms
Infection
Costs
Abreviations:
HAI
ICU
KPS
LOS
SD
Resumen
Objetivos

Analizar la relación entre la presencia de infección nosocomial y el resultado clínico final, la duración de la estancia y el coste del episodio en los pacientes diagnosticados de tumoración cerebral en nuestro servicio.

Material y método

Realizamos un estudio retrospectivo incluyendo los pacientes ingresados en el Servicio de Neurocirugía del Hospital Universitario de Cruces con diagnostico de tumoración cerebral en el periodo comprendido entre el 1-1-2007 y el 31-12 del 2007. Recogimos variables demográficas, los microorganismos responsables y la localización de las distintas infecciones, el tiempo de ingreso y los costes de los distintos procedimientos médicos y quirúrgicos realizados.

Resultados

Recogimos 139 pacientes, que acumularon un total de 210 episodios. Encontramos la presencia de infecciones nosocomiales en 34 episodios (16,25%). La localización mas frecuente fue la respiratoria, seguida del tracto urinario y la infección de herida quirúrgica. Encontramos unas diferencias significativas en la situación funcional al alta (sig <0.01), el coste medio de los episodios (17097€, sig.<0.01) y en la estancia media (15.45 días, sig.<0.01). No encontramos diferencias significativas con respecto a la mortalidad.

Conclusiones

Encontramos asociaciones significativas entre la presencia de infección nosocomial, un peor resultado clínico, un mayor coste y una mayor estancia. Los gérmenes responsables y localizaciones fueron similares a las series previamente publicadas. A pesar de que la variabilidad en el diseño de los estudios recogidos en la literatura dificulta la interpretación y comparación de los resultados, las medidas destinadas a la prevención de esta complicación permiten simultáneamente mejorar la asistencia prestada, asi como reducir los costes generados por la enfermedad.

Palabras clave:
Tumor cerebral
Infección
Costes
El Texto completo solo esta disponible en PDF
References
[1.]
D.J. Anderson
Underresourced hospital infection control and prevention programs: penny wise, pound foolish?
Infect Control Hosp Epidemiol, 28 (2007), pp. 767-773 http://dx.doi.org/10.1086/518518
[2.]
J.S. Barnholtz-Sloan
Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma
J Neurosurg, 108 (2008), pp. 642-648 http://dx.doi.org/10.3171/JNS/2008/108/4/0642
[3.]
P. Blomqvist
Brain tumours in Sweden 1996: care and costs
J Neurol Neurosurg Psychiatry, 69 (2000), pp. 792-798
[4.]
H. Burgmann
Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients
Intensive Care Med, 36 (2010), pp. 1597-1601 http://dx.doi.org/10.1007/s00134-010-1941-2
[5.]
J.P. Burke
Infection control - a problem for patient safety
N Engl J Med, 348 (2003), pp. 651-656 http://dx.doi.org/10.1056/NEJMhpr020557
[6.]
D.J. Byrne
Wound infection rates: the importance of definition and post-discharge wound surveillance
J Hosp Infect, 26 (1994), pp. 37-43
[7.]
K.L. Chaichana
Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients
Ann Surg Oncol, 18 (2011), pp. 239-245 http://dx.doi.org/10.1245/s10434-010-1242-6
[8.]
Y.Y. Chen,Y.C. Chou,P. Chou
Impact of nosocomial infection on cost of illness and length of stay in intensive care units
Infect Control Hosp Epidemiol, 26 (2005), pp. 281-287 http://dx.doi.org/10.1086/502540
[9.]
D.R. Cohen
Economic issues in infection control
J Hosp Infect, 5 (1984), pp. 17-25
[10.]
M.F. Drummond,L.M. Davies
Evaluation of the costs and benefits of reducing hospital infection
J Hosp Infect, 18 (1991), pp. 85-93
[11.]
S. Dulworth,B. Pyenson
Healthcare-associated infections and length of hospital stay in the Medicare population
Am J Med Qual, 19 (2004), pp. 121-127
[12.]
M. Ekman,M. Westphal
Cost of brain tumour in Europe
[13.]
N. Graves
Estimating the cost of health careassociated infections: mind your p's and q's
Clin Infect Dis, 50 (2010), pp. 1017-1021 http://dx.doi.org/10.1086/651110
[14.]
N. Graves
Economics and preventing hospital-acquired infection
Emerg Infect Dis, 10 (2004), pp. 561-566 http://dx.doi.org/10.3201/eid1004.020754
[15.]
R. Grossman
Predictors of inpatient death and complications among postoperative elderly patients with metastatic brain tumors
Ann Surg Oncol, 18 (2011), pp. 521-528 http://dx.doi.org/10.1245/s10434-010-1299-2
[16.]
T.C. Horan,M. Andrus,M.A. Dudeck
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Am J Infect Control, 36 (2008), pp. 309-332 http://dx.doi.org/10.1016/j.ajic.2008.03.002
[17.]
M.L. Kilgore
The costs of nosocomial infections
[18.]
K.B. Kirkland
The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs
Infect Control Hosp Epidemiol, 20 (1999), pp. 725-730 http://dx.doi.org/10.1086/501572
[19.]
R.J. Lagoe,G.P. Westert
Evaluation of hospital inpatient complications: a planning approach
BMC Health Serv Res, 10 (2010), pp. 200 http://dx.doi.org/10.1186/1472-6963-10-200
[20.]
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470–485.
[21.]
P.M. Olaechea
Epidemiology and impact of nosocomial infections
Med Intensiva, 34 (2010), pp. 256-267 http://dx.doi.org/10.1016/j.medin.2009.11.013
[22.]
P.M. Olaechea
Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit
Infect Control Hosp Epidemiol, 24 (2003), pp. 207-213 http://dx.doi.org/10.1086/502191
[23.]
G.B. Orsi
Hospital-acquired infection surveillance in a neurosurgical intensive care unit
J Hosp Infect, 64 (2006), pp. 23-29 http://dx.doi.org/10.1016/j.jhin.2006.02.022
[24.]
M.M. Peng,S. Kurtz,R.S. Johannes
Adverse outcomes from hospital-acquired infection in Pennsylvania cannot be attributed to increased risk on admission
Am J Med Qual, 21 (2006), pp. 17S-28S http://dx.doi.org/10.1177/1062860606294632
[25.]
E.N. Perencevich
Raising standards while watching the bottom line: making a business case for infection control
Infect Control Hosp Epidemiol, 28 (2007), pp. 1121-1133 http://dx.doi.org/10.1086/521852
[26.]
R. Plowman
The rate and cost of hospitalacquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed
J Hosp Infect, 47 (2001), pp. 198-209 http://dx.doi.org/10.1053/jhin.2000.0881
[27.]
R.R. Roberts
Costs attributable to healthcareacquired infection in hospitalized adults and a comparison of economic methods
[28.]
N. Safdar
Clinical and economic consequences of ventilator-associated pneumonia: a systematic review
Crit Care Med, 33 (2005), pp. 2184-2193
[29.]
S. Saint,C. Chenoweth,A.M. Fendrick
The role of economic evaluation in infection control
Am J Infect Control, 29 (2001), pp. 338-344
[30.]
W.E. Scheckler
Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America
Infect Control Hosp Epidemiol, 19 (1998), pp. 114-124
[31.]
W.H. Sheng
Comparative impact of hospitalacquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres
J Hosp Infect, 59 (2005), pp. 205-214 http://dx.doi.org/10.1016/j.jhin.2004.06.003
[32.]
P.W. Stone,D. Braccia,E. Larson
Systematic review of economic analyses of health care-associated infections
Am J Infect Control, 33 (2005), pp. 501-509 http://dx.doi.org/10.1016/j.ajic.2005.04.246
[33.]
P.W. Stone,L. Kunches,L. Hirschhorn
Cost of hospital-associated infections in Massachusetts
Am J Infect Control, 37 (2009), pp. 210-214 http://dx.doi.org/10.1016/j.ajic.2008.07.011
[34.]
P.W. Stone
Economic burden of healthcare-associated infections: an American perspective
Expert Rev Pharmacoecon Outcomes Res, 9 (2009), pp. 417-422 http://dx.doi.org/10.1586/erp.09.53
[35.]
R.A. Weinstein
Nosocomial infection update
Emerg Infect Dis, 4 (1998), pp. 416-420 http://dx.doi.org/10.3201/eid0403.980320
[36.]
P. Ylipalosaari
Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study
Crit Care, 10 (2006), pp. R66 http://dx.doi.org/10.1186/cc4902

Undabeitia, J.; Liu, B.G.; Catalán, G.; Bilbao, G.; Pomposo, I.; Garibi, J.M.: Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital. Neurocirugía 2011; 22: 535–541.

Copyright © 2011. Sociedad Española de Neurocirugía
Neurocirugía (English edition)

Subscribe to our Newsletter

Article options
Tools
Cookies policy
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.